Skip to main content
Clinical Trials/NCT02342938
NCT02342938
Completed
Not Applicable

Simultaneous MEG or fMRI And INtracranial EEG

Hospices Civils de Lyon1 site in 1 country47 target enrollmentSeptember 16, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Hospices Civils de Lyon
Enrollment
47
Locations
1
Primary Endpoint
Blood Oxygenation Level Dependent changes, associated with intracranial EEG signal, as determined by simultaneous fMRI and icEEG
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

The SEMAINE project will investigate intracranial EEG (icEEG) simultaneously recorded with either fMRI or MEG to 1) improve identification of the epileptogenic zone in patients suffering from drug-resistant partial epilepsy, and 2) define the functional organization of neural networks underlying human perception and cognition in order to prevent inadvertent deficits resulting from neurosurgical resection. In particular, high-frequency activity (HFA), as measured with icEEG, has been demonstrated in recent years as a relevant index for both epileptogenic tissue and healthy cortical processing, but its correlates in fMRI and MEG require further investigation. This will be a pioneering effort in several respects, as the first to directly measure high-frequency neural activity in tandem with fMRI, and among the first to do so with MEG. In addition to their attractiveness as noninvasive imaging techniques, fMRI and MEG have the potential to examine whole-brain networks that are not accessible to icEEG's necessarily limited spatial coverage. Furthermore, such a campaign of simultaneous recordings will take unprecedented advantage of icEEG as the bridge between the two noninvasive techniques, providing compelling evidence for the links between all three measurements with respect to underlying high-frequency neural activity in both health and disease. This project will therefore lead to improved selection of epilepsy surgery candidates and improved neurosurgical outcomes from the precise mapping of epileptogenic and healthy brain networks. The same techniques will be immediately applicable to functional mapping of other types of neurosurgery populations as well as diagnostic neuroimaging of neurological and psychiatric populations.

Registry
clinicaltrials.gov
Start Date
September 16, 2013
End Date
May 18, 2017
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 18 and 60 years, not subject of any measure of legal protection
  • Patients suffering from drug resistant partial epilepsy
  • Patient undergoing intracranial video EEG
  • Patients with electrodes implanted in orthogonal
  • no MRI cons-indication
  • Patients who signed a consent form
  • Intellectual capacity to perform cognitive tasks and to sign an informed consent.
  • Affiliation to social security

Exclusion Criteria

  • Pregnant women
  • Elderly patients under 18 or over 60 years Patient not suffering from drug resistant partial epilepsy, or not scheduled for a SEEG
  • MRI cons-indication
  • Patients taking psychotropics drugs
  • Claustrophobia
  • Inability to perform cognitive tasks or to give informed consent.

Outcomes

Primary Outcomes

Blood Oxygenation Level Dependent changes, associated with intracranial EEG signal, as determined by simultaneous fMRI and icEEG

Time Frame: Month 2

fMRI correlates of epileptic and cognitive-induced high-frequency activities

MEG signal, associated with intracranial EEG signal, as determined by simultaneous MEG and icEEG

Time Frame: Month 2

MEG correlates of epileptic and cognitive-induced high-frequency activities

Study Sites (1)

Loading locations...

Similar Trials